Designing a multi-arm multi-stage trial for Parkinson’s
Objective: The Edmond J Safra ACT-PD initiative (EJS ACT-PD) is developing the first multi-arm multi-stage (MAMS) platform trial for potential disease modifying approaches for Parkinson’s…Spectral somatotopy of the human subthalamic nucleus in Parkinson’s disease
Objective: This study aims to systematically investigate the spatial segregation of a wide range of spectral features of local field potentials (LFPs) within the STN…Social cognition in Parkinson’s disease
Objective: Objective: To assess deficits in social cognition among patients with Parkinson’s Disease (PD) Background: Background: Social cognition is the study of how people make…Utilisation of the Clinical Frailty Scale to prompt transfer of patients with Parkinson’s disease from Neurology to Geriatric Medicine services.
Objective: The aim of this study was to determine the feasibility of the Clinical Frailty Scale (CFS) as a tool to trigger clinicians' transfer of…MRI biomarkers of freezing of gait development in in Parkinson’s disease
Objective: This study investigated longitudinal clinical, structural and functional brain alterations in Parkinson’s disease patients with freezing of gait (PD-FoG) and in those developing (PD-FoG-converters)…Heterozygous mutations in the Parkin gene – two different presentations of Parkinson’s disease
Objective: The main objective of this work is to present two Parkinson's disease (PD) patients with heterozygous mutations in the Parkin gene (PARK – parkin)…A Single-Centre Canadian Study of Disparities in Access to Deep Brain Stimulation for Movement Disorders
Objective: To identify disparities in gender and ethnicity among deep brain stimulation (DBS) patients to reduce differences in access to care by implementing strategies to…POOR SLEEP QUALITY AND OBESITY IN PATIENTS WITH PARKINSON’S: PRELIMINARY RESULTS OF A COHORT STUDY
Objective: Describe the prevalence of overweight and obesity in patients with PD who have poor quality sleep. Background: Sleep disturbances are common and often severe…Merging global cohorts of manifesting and non-manifesting carriers of pathogenic variants in known Parkinson’s disease genes
Objective: To create a global cohort of manifesting and non-manifesting carriers of pathogenic variants in known monogenic Parkinson's disease (PD) genes, such as LRRK2, PRKN, and PINK1, to better…What, when and how should the information on iRBD and risk of Parkinson’s disease and related conditions be communicated?
Objective: To investigate what, when and how patients with iRBD would like to receive information regarding the potential future implications of having iRBD, once diagnosis…
- « Previous Page
- 1
- …
- 365
- 366
- 367
- 368
- 369
- …
- 436
- Next Page »